Elanco Animal Health Inc - Company Profile
Powered by
All the data and insights you need on Elanco Animal Health Inc in one report.
- Save hours of research time and resources with
our up-to-date Elanco Animal Health Inc Strategy Report
- Understand Elanco Animal Health Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Business Description
Elanco Animal Health Inc (Elanco) is a producer and seller of animal health products which include parasiticides, vaccines, therapeutics, medicated feed additives, injectable antibiotics, insecticides, antibacterial, anticoccidials, and enzymes. The company distributes its products to more than 90 countries, globally. Some of its major products as per brand name include Seresto, Rumensin, Advocate, Advantix, Maxiban, Advantix, Advantage, Advocate, Atopica, Claro, Credelio, TruCan, and Baycox, among others. It has 18 global manufacturing sites with approximately 150 CMOs in Brazil, China, France, Germany, Mexico, New Zealand, South Korea, Taiwan, Vietnam, and the US. The company in FY2022, had approximately 200 brands under its name. Elanco classifies its business operations into three product categories Pet Health, Farm Animal, and Contract Manufacturing. In FY2022, the company’s capital expenditure stood at US$184 million, which decreased 6.6% YoY.
R&D Overview
One of the major pillars of Elanco is innovation, which benefits the company from the R&D conducted by its in-house research. New product development is one of the core business strategies of the company. The company's approach is to build or buy assets to develop new products with the help of Elanco’s scientists, and innovators; and have partnerships with academia, agribusiness, human pharmaceutical companies, agriculture, and biotechnology organizations. The company’s major focus under R&D is to create novel products with new active ingredients in seven areas across pets and farm animals: therapeutics, vaccines, monoclonals, parasiticides, pharmaceuticals, vaccines, and sustainable animal protein projects. Moreover, Elanco for its R&D development applies large and small-molecule approaches for both farm animals and pets. The company in FY2022, had R&D sites in Australia, Germany, Brazil, China, India, Switzerland, and the US. In FY2022, the company spent US$321 million on R&D, which as a percentage of revenue, stood at 7% and decreased 13% YoY. As of December 2022, the company had 6,500 patents and applications, filed in over 90 countries, and more than 14,500 trademark applications and registrations in major regions, primarily identifying products dedicated to the care of livestock and pets.
Product Categories
Overview
Offers manufacture products on behalf of a third party, including supply agreements associated with divestitures of products.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Offers products such as medicated feed additives, injectable antibiotics, vaccines, insecticides, and enzymes, among others through brands such as Rumensin, Baytril, and Maxiban catering to the therapy areas such as Newcastle disease, infectious bronchitis, fowl cholera, paramyxovirus type 3, bursal disease, salmonella, isopora suis infection, respiratory diseases, dysentery. It also caters to enzyme supplements, and coccidiosis in broiler chickens, and to prevents mortality caused by necrotic enteritis.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Offers products such as parasiticides, vaccines, and therapeutics under the brand names of Seresto and Advantage, Advantix, Advocate, Credelio, Interceptor Plus, Trifexis, Galliprant, and Claro catering to the therapy areas such as otitis externa, flea infestations, tick infestations, distemper, adenovirus, parvovirus, corona, parainfluenza, leptospira canicola, osteoarthritis, irofilarial immitis, hookworms, among others.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Geographical Segments
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer